Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 26
Filtrar
1.
Chem Biol Drug Des ; 91(2): 552-566, 2018 02.
Artículo en Inglés | MEDLINE | ID: mdl-29034580

RESUMEN

Transient receptor potential melastatin-2 (TRPM2) channel critical for monitoring internal body temperature is implicated in the pathological processes such as neurodegeneration. However, lacking selective and potent TRPM2 inhibitors impedes investigation and validation of the channel as a drug target. To discover novel and selective TRPM2 inhibitors, a series of adenosine 5'-diphosphoribose analogues were synthesized, and their activities and selectivity were evaluated. Whole-cell patch-clamp recordings were employed for screen and evaluation of synthesized compounds. Two compounds, 7i and 8a, were identified as TRPM2 inhibitors with IC50 of 5.7 and 5.4 µm, respectively. Both 7i and 8a inhibited TRPM2 current without affecting TRPM7, TRPM8, TRPV1 and TRPV3. These two TRPM2 inhibitors can serve as new pharmacological tools for further investigation and validation of TRPM2 channel as a drug target, and the summarized structure-activity relationship (SAR) may also provide insights into further improving existing inhibitors as potential lead compounds.


Asunto(s)
Adenosina Difosfato Ribosa/análogos & derivados , Canales Catiónicos TRPM/metabolismo , Adenosina Difosfato Ribosa/síntesis química , Adenosina Difosfato Ribosa/metabolismo , Calcio/metabolismo , Células HEK293 , Humanos , Concentración 50 Inhibidora , Técnicas de Placa-Clamp , Isoformas de Proteínas/antagonistas & inhibidores , Isoformas de Proteínas/genética , Isoformas de Proteínas/metabolismo , Relación Estructura-Actividad , Canales Catiónicos TRPM/antagonistas & inhibidores , Canales Catiónicos TRPM/genética
2.
Chembiochem ; 18(16): 1616-1626, 2017 08 17.
Artículo en Inglés | MEDLINE | ID: mdl-28589630

RESUMEN

The design of a bioreversibly protected lipophilic sugar nucleotide as a potential membrane-permeable precursor of adenosine diphosphate ribose (ADPR) is described. ADPR is the most potent activator of the transient receptor potential melastatin 2 (TRPM2) ion channel. Membrane-permeable, lipophilic derivatives of ADPR are of great interest as tools for study of the mechanism of TRPM2. The approach described here was based on our recently disclosed "DiPPro" and "TriPPPro" prodrug approaches developed for the intracellular delivery of nucleotides. A lipophilic, bioreversibly masked ADPR analogue containing an enzymatically cleavable 4-pentanoyloxybenzyl (PB) mask at the phosphate moiety next to the 5'-position of adenosine, together with O-acetyl groups, was prepared in high yields. Chemical and enzymatic hydrolysis studies in phosphate buffer (pH 7.3) were performed to assess chemical stability and possible (selective) enzymatic demasking of the ADPR analogue. HPLC-MS revealed that the PB group was readily cleaved enzymatically. In addition, the formation of partially deacetylated ADPR compounds and also of fully unprotected ADPR was observed.


Asunto(s)
Adenosina Difosfato Ribosa/análogos & derivados , Adenosina Difosfato Ribosa/síntesis química , Profármacos/síntesis química , Adenosina Difosfato Ribosa/química , Animales , Hidrolasas de Éster Carboxílico/química , Estabilidad de Medicamentos , Concentración de Iones de Hidrógeno , Hidrólisis , Profármacos/química , Porcinos
3.
Biochem Soc Trans ; 43(3): 417-25, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-26009185

RESUMEN

Synthetic compounds open up new avenues to interrogate and manipulate intracellular Ca2+ signalling pathways. They may ultimately lead to drug-like analogues to intervene in disease. Recent advances in chemical biology tools available to probe Ca2+ signalling are described, with a particular focus on those synthetic analogues from our group that have enhanced biological understanding or represent a step towards more drug-like molecules. Adenophostin (AdA) is the most potent known agonist at the inositol 1,4,5-trisphosphate receptor (IP3R) and synthetic analogues provide a binding model for receptor activation and channel opening. 2-O-Modified inositol 1,4,5-trisphosphate (IP3) derivatives that are partial agonists at the IP3R reveal key conformational changes of the receptor upon ligand binding. Biphenyl polyphosphates illustrate that simple non-inositol surrogates can be engineered to give prototype IP3R agonists or antagonists and act as templates for protein co-crystallization. Cyclic adenosine 5'-diphosphoribose (cADPR) can be selectively modified using total synthesis, generating chemically and biologically stable tools to investigate Ca2+ release via the ryanodine receptor (RyR) and to interfere with cADPR synthesis and degradation. The first neutral analogues with a synthetic pyrophosphate bioisostere surprisingly retain the ability to release Ca2+, suggesting a new route to membrane-permeant tools. Adenosine 5'-diphosphoribose (ADPR) activates the Ca2+-, Na+- and K+-permeable transient receptor potential melastatin 2 (TRPM2) cation channel. Synthetic ADPR analogues provide the first structure-activity relationship (SAR) for this emerging messenger and the first functional antagonists. An analogue based on the nicotinic acid motif of nicotinic acid adenine dinucleotide phosphate (NAADP) antagonizes NAADP-mediated Ca2+ release in vitro and is effective in vivo against induced heart arrhythmia and autoimmune disease, illustrating the therapeutic potential of targeted small molecules.


Asunto(s)
Adenosina Difosfato Ribosa/química , Arritmias Cardíacas/tratamiento farmacológico , Señalización del Calcio/efectos de los fármacos , Calcio/metabolismo , Bibliotecas de Moléculas Pequeñas/uso terapéutico , Adenosina/análogos & derivados , Adenosina/química , Adenosina/uso terapéutico , Adenosina Difosfato Ribosa/análogos & derivados , Adenosina Difosfato Ribosa/síntesis química , Arritmias Cardíacas/patología , Bloqueadores de los Canales de Calcio/uso terapéutico , Humanos , Inositol 1,4,5-Trifosfato/genética , Inositol 1,4,5-Trifosfato/metabolismo , Receptores de Inositol 1,4,5-Trifosfato/antagonistas & inhibidores , NADP/análogos & derivados , NADP/antagonistas & inhibidores , Canal Liberador de Calcio Receptor de Rianodina/efectos de los fármacos , Canal Liberador de Calcio Receptor de Rianodina/genética , Bibliotecas de Moléculas Pequeñas/síntesis química , Bibliotecas de Moléculas Pequeñas/química , Relación Estructura-Actividad
4.
J Am Chem Soc ; 137(10): 3558-64, 2015 Mar 18.
Artículo en Inglés | MEDLINE | ID: mdl-25706250

RESUMEN

Poly(ADP-ribosyl)ation is a common post-translational modification that mediates a wide variety of cellular processes including DNA damage repair, chromatin regulation, transcription, and apoptosis. The difficulty associated with accessing poly(ADP-ribose) (PAR) in a homogeneous form has been an impediment to understanding the interactions of PAR with poly(ADP-ribose) glycohydrolase (PARG) and other binding proteins. Here we describe the chemical synthesis of the ADP-ribose dimer, and we use this compound to obtain the first human PARG substrate-enzyme cocrystal structure. Chemical synthesis of PAR is an attractive alternative to traditional enzymatic synthesis and fractionation, allowing access to products such as dimeric ADP-ribose, which has been detected but never isolated from natural sources. Additionally, we describe the synthesis of an alkynylated dimer and demonstrate that this compound can be used to synthesize PAR probes including biotin and fluorophore-labeled compounds. The fluorescently labeled ADP-ribose dimer was then utilized in a general fluorescence polarization-based PAR-protein binding assay. Finally, we use intermediates of our synthesis to access various PAR fragments, and evaluation of these compounds as substrates for PARG reveals the minimal features for substrate recognition and enzymatic cleavage. Homogeneous PAR oligomers and unnatural variants produced from chemical synthesis will allow for further detailed structural and biochemical studies on the interaction of PAR with its many protein binding partners.


Asunto(s)
Adenosina Difosfato Ribosa/química , Adenosina Difosfato Ribosa/síntesis química , Dimerización , Glicósido Hidrolasas/metabolismo , Cristalografía por Rayos X , Glicósido Hidrolasas/química , Glicosilación , Humanos , Modelos Moleculares , Conformación Proteica
5.
J Med Chem ; 56(24): 10079-102, 2013 Dec 27.
Artículo en Inglés | MEDLINE | ID: mdl-24304219

RESUMEN

Adenosine 5'-diphosphoribose (ADPR) activates TRPM2, a Ca(2+), Na(+), and K(+) permeable cation channel. Activation is induced by ADPR binding to the cytosolic C-terminal NudT9-homology domain. To generate the first structure-activity relationship, systematically modified ADPR analogues were designed, synthesized, and evaluated as antagonists using patch-clamp experiments in HEK293 cells overexpressing human TRPM2. Compounds with a purine C8 substituent show antagonist activity, and an 8-phenyl substitution (8-Ph-ADPR, 5) is very effective. Modification of the terminal ribose results in a weak antagonist, whereas its removal abolishes activity. An antagonist based upon a hybrid structure, 8-phenyl-2'-deoxy-ADPR (86, IC50 = 3 µM), is more potent than 8-Ph-ADPR (5). Initial bioisosteric replacement of the pyrophosphate linkage abolishes activity, but replacement of the pyrophosphate and the terminal ribose by a sulfamate-based group leads to a weak antagonist, a lead to more drug-like analogues. 8-Ph-ADPR (5) inhibits Ca(2+) signalling and chemotaxis in human neutrophils, illustrating the potential for pharmacological intervention at TRPM2.


Asunto(s)
Adenosina Difosfato Ribosa/farmacología , Diseño de Fármacos , Canales Catiónicos TRPM/antagonistas & inhibidores , Adenosina Difosfato Ribosa/síntesis química , Adenosina Difosfato Ribosa/química , Relación Dosis-Respuesta a Droga , Humanos , Modelos Moleculares , Estructura Molecular , Relación Estructura-Actividad
6.
J Am Chem Soc ; 132(14): 5236-40, 2010 Apr 14.
Artículo en Inglés | MEDLINE | ID: mdl-20232863

RESUMEN

Adenosine diphosphate ribosylation (ADP-ribosylation) is a widely occurring post-translational modification of proteins at nucleophilic side chains of amino acid residues, such as asparagine, glutamic acid, and arginine. Elucidation of the biological role of ADP-ribosylation events would benefit from the availability of well-defined ADP-ribosylated peptides. Main issues in the construction of synthetic ADP-ribosylated peptides involve the availability of protected ribosylated amino acids suitable for peptide synthesis, development of a protective group strategy for peptide fragments compatible with the integrity of the adenosine diphosphate moiety, and an efficient procedure for pyrophosphate formation. In this paper we present a first approach to the chemical synthesis of ADP-ribosylated peptides in solution and on solid support. We describe an efficient synthesis of suitably protected ribosylated asparagine and glutamine building blocks suitable for Fmoc-based peptide synthesis. We further demonstrate a successful application of these ribosylated amino acids in the assembly of three fully synthetic ADP-ribosylated peptides by solution and solid phase approaches.


Asunto(s)
Adenosina Difosfato Ribosa/síntesis química , Asparagina/química , Glutamina/química , Oligopéptidos/síntesis química , Adenosina Difosfato Ribosa/química , Estructura Molecular , Oligopéptidos/química , Estereoisomerismo
7.
Nucleosides Nucleotides Nucleic Acids ; 27(10): 1127-43, 2008 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-18788043

RESUMEN

[See figures]. The synthesis of analogues of adenosine diphosphate ribose and acetylated adenosine diphosphate ribose, modified at the northern pentose, is reported. The stereochemistry at the acetylated centers was chosen to minimize acetyl migration and dictated the overall synthetic strategy.


Asunto(s)
Adenosina Difosfato Ribosa/análogos & derivados , Adenosina Difosfato Ribosa/síntesis química , Acetilación , Estructura Molecular
8.
Org Biomol Chem ; 5(16): 2541-54, 2007 Aug 21.
Artículo en Inglés | MEDLINE | ID: mdl-18019526

RESUMEN

ADP-ribosylation using nicotinamide adenine dinucleotide (NAD+) is an important type of enzymatic reaction that affects many biological processes. A brief introductory review is given here to various ADP-ribosyltransferases, including poly(ADP-ribose) polymerase (PARPs), mono(ADP-ribosyl)-transferases (ARTs), NAD(+)-dependent deacetylases (sirtuins), tRNA 2'-phosphotransferases, and ADP-ribosyl cyclases (CD38 and CD157). Focus is given to the enzymatic reactions, mechanisms, structures, and biological functions.


Asunto(s)
NAD/química , NAD/fisiología , Adenosina Difosfato Ribosa/síntesis química , Adenosina Difosfato Ribosa/química , Adenosina Difosfato Ribosa/metabolismo , Animales , Humanos , Modelos Moleculares , Conformación Molecular , Oxidación-Reducción
9.
J Immunol ; 179(11): 7827-39, 2007 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-18025229

RESUMEN

The ectoenzyme CD38 catalyzes the production of cyclic ADP-ribose (cADPR) and ADP-ribose (ADPR) from its substrate, NAD(+). Both products of the CD38 enzyme reaction play important roles in signal transduction, as cADPR regulates calcium release from intracellular stores and ADPR controls cation entry through the plasma membrane channel TRPM2. We previously demonstrated that CD38 and the cADPR generated by CD38 regulate calcium signaling in leukocytes stimulated with some, but not all, chemokines and controls leukocyte migration to inflammatory sites. However, it is not known whether the other CD38 product, ADPR, also regulates leukocyte trafficking In this study we characterize 8-bromo (8Br)-ADPR, a novel compound that specifically inhibits ADPR-activated cation influx without affecting other key calcium release and entry pathways. Using 8Br-ADPR, we demonstrate that ADPR controls calcium influx and chemotaxis in mouse neutrophils and dendritic cells activated through chemokine receptors that rely on CD38 and cADPR for activity, including mouse FPR1, CXCR4, and CCR7. Furthermore, we show that the calcium and chemotactic responses of leukocytes are not dependent on poly-ADP-ribose polymerase 1 (PARP-1), another potential source of ADPR in some leukocytes. Finally, we demonstrate that NAD(+) analogues specifically block calcium influx and migration of chemokine-stimulated neutrophils without affecting PARP-1-dependent calcium responses. Collectively, these data identify ADPR as a new and important second messenger of mouse neutrophil and dendritic cell migration, suggest that CD38, rather than PARP-1, may be an important source of ADPR in these cells, and indicate that inhibitors of ADPR-gated calcium entry, such as 8Br-ADPR, have the potential to be used as anti-inflammatory agents.


Asunto(s)
ADP-Ribosil Ciclasa 1/metabolismo , Adenosina Difosfato Ribosa/análogos & derivados , Adenosina Difosfato Ribosa/farmacología , Células de la Médula Ósea/efectos de los fármacos , Quimiotaxis/efectos de los fármacos , Neutrófilos/efectos de los fármacos , ADP-Ribosil Ciclasa 1/deficiencia , Adenosina Difosfato Ribosa/síntesis química , Adenosina Difosfato Ribosa/química , Animales , Células de la Médula Ósea/inmunología , Calcio/antagonistas & inhibidores , Calcio/inmunología , Línea Celular , Quimiotaxis/inmunología , Células Dendríticas/efectos de los fármacos , Células Dendríticas/inmunología , Leucocitos/efectos de los fármacos , Leucocitos/inmunología , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , NAD/análogos & derivados , NAD/farmacología , Neutrófilos/inmunología , Poli(ADP-Ribosa) Polimerasa-1 , Poli(ADP-Ribosa) Polimerasas/inmunología , Sensibilidad y Especificidad , Relación Estructura-Actividad , Factores de Tiempo
10.
Org Lett ; 6(20): 3461-4, 2004 Sep 30.
Artículo en Inglés | MEDLINE | ID: mdl-15387523

RESUMEN

[structure: see text] The synthesis of the bisphosphonate ADP-ribose, in which acetylene has replaced the oxygen of the pyrophosphate linkage, is reported.


Asunto(s)
Adenosina Difosfato Ribosa/análogos & derivados , Adenosina Difosfato Ribosa/síntesis química , Difosfonatos/síntesis química , Adenosina Difosfato Ribosa/química , Catálisis , Difosfonatos/química , Indicadores y Reactivos , Estructura Molecular , Resonancia Magnética Nuclear Biomolecular
11.
Biochemistry ; 41(21): 6744-51, 2002 May 28.
Artículo en Inglés | MEDLINE | ID: mdl-12022878

RESUMEN

Three novel analogues modified in the "northern" ribose (ribose linked to N1 of adenine) of the Ca(2+) mobilizing second messenger cyclic adenosine diphosphoribose, termed 2"-NH(2)-cyclic adenosine diphosphoribose, cyclic adenosine diphospho-carbocyclic-ribose, and 8-NH(2)-cyclic adenosine diphospho-carbocyclic-ribose, were synthesized (chemoenzymatically and by total synthesis) and spectroscopically characterized, and the pK(a) values for the 6-amino/imino transition were determined in two cases. The biological activity of these analogues was determined in permeabilized human Jurkat T-lymphocytes. 2"-NH(2)-cyclic adenosine diphosphoribose mediated Ca(2+) release was slightly more potent than that of the endogenous cyclic adenosine diphosphoribose in terms of the concentration-reponse relationship. Both compounds released Ca(2+) from the same intracellular Ca(2+) pool. In addition, the control compound 2"-NH(2)-adenosine diphosphoribose was almost without effect. In contrast, only at much higher concentrations (> or =50 microM) did the "northern" carbocyclic analogue, cyclic adenosine diphospho-carbocyclic-ribose, significantly release Ca(2+) from permeabilized T cells, whereas the previously reported "southern" carbocyclic analogue, cyclic aristeromycin diphosphoribose, was slightly more active than the endogenous cyclic adenosine diphosphoribose. Likewise, 8-NH(2)-cyclic adenosine diphospho-carbocyclic-ribose, expected to antagonize Ca(2+) release as demonstrated previously for 8-NH(2)-cyclic adenosine diphosphoribose, did not inhibit cyclic adenosine diphosphoribose mediated Ca(2+) release. This indicates that the 2"-NH(2)-group substitutes well for the 2"-OH-group it replaces; it may be oriented toward the outside of the putative cyclic adenosine diphosphoribose receptor binding domain and/or it can potentially also engage in H bonding interactions with residues of that domain. In sharp contrast to this, replacement of the endocyclic furanose oxygen atom by CH(2) in a carbocyclic system obviously interferes with a crucial element of interaction between cyclic adenosine diphosphoribose and its receptor in T-lymphocytes.


Asunto(s)
Adenosina Difosfato Ribosa/química , Adenosina Difosfato Ribosa/farmacología , Calcio/metabolismo , ADP-Ribosa Cíclica/análogos & derivados , Sistemas de Mensajero Secundario/fisiología , Adenosina Difosfato Ribosa/análogos & derivados , Adenosina Difosfato Ribosa/síntesis química , Transporte Biológico , Relación Dosis-Respuesta a Droga , Humanos , Hidrólisis , Células Jurkat , Cinética
12.
Biochemistry ; 40(51): 15456-63, 2001 Dec 25.
Artículo en Inglés | MEDLINE | ID: mdl-11747420

RESUMEN

The Sir2 enzyme family is responsible for a newly classified chemical reaction, NAD(+)-dependent protein deacetylation. New peptide substrates, the reaction mechanism, and the products of the acetyl transfer to NAD(+) are described for SIR2. The final products of SIR2 reactions are the deacetylated peptide and the 2' and 3' regioisomers of O-acetyl ADP ribose (AADPR), formed through an alpha-1'-acetyl ADP ribose intermediate and intramolecular transesterification reactions (2' --> 3'). The regioisomers, their anomeric forms, the interconversion rates, and the reaction equilibria were characterized by NMR, HPLC, 18O exchange, and MS methods. The mechanism of acetyl transfer to NAD(+) includes (1) ADP ribosylation of the peptide acyl oxygen to form a high-energy O-alkyl amidate intermediate, (2) attack of the 2'-OH group on the amidate to form a 1',2'-acyloxonium species, (3) hydrolysis to 2'-AADPR by the attack of water on the carbonyl carbon, and (4) an SIR2-independent transesterification equilibrating the 2'- and 3'-AADPRs. This mechanism is unprecedented in ADP-ribosyl transferase enzymology. The 2'- and 3'-AADPR products are candidate molecules for SIR2-initiated signaling pathways.


Asunto(s)
Adenosina Difosfato Ribosa/análogos & derivados , Adenosina Difosfato Ribosa/síntesis química , Silenciador del Gen , Histona Desacetilasas/química , NAD/química , Proteínas Reguladoras de Información Silente de Saccharomyces cerevisiae , Transactivadores/química , Adenosina Difosfato Ribosa/química , Adenosina Difosfato Ribosa/metabolismo , Secuencia de Aminoácidos , Arabinosa/química , Proteínas Arqueales/química , Proteínas Arqueales/genética , Proteínas Bacterianas/química , Proteínas Bacterianas/genética , Óxido de Deuterio/metabolismo , Inhibidores Enzimáticos/química , Proteínas Fúngicas/química , Proteínas Fúngicas/genética , Inhibidores de Histona Desacetilasas , Histona Desacetilasas/genética , Histona Desacetilasas/metabolismo , Humanos , Isomerismo , Cinética , Datos de Secuencia Molecular , NAD/metabolismo , Resonancia Magnética Nuclear Biomolecular , O-Acetil-ADP-Ribosa , Isótopos de Oxígeno/metabolismo , Sirtuina 1 , Sirtuina 2 , Sirtuinas , Especificidad por Sustrato , Transactivadores/antagonistas & inhibidores , Transactivadores/genética , Transactivadores/metabolismo
13.
Artículo en Inglés | MEDLINE | ID: mdl-11563021

RESUMEN

An efficient synthesis of cyclic ADP-carbocyclic-ribose (2), as a stable mimic for cyclic ADP-ribose, was achieved. Treatment of N1-carbocyclic-ribosyladenosine bisphosphate derivative 10 with AgNO3 in the presence of molecular sieves 3A in pyridine gave the desired cyclic product in 93% yield, which was deprotected to give the target cyclic ADP-carbocyclic-ribose (2).


Asunto(s)
Adenosina Difosfato Ribosa/análogos & derivados , Adenosina Difosfato Ribosa/síntesis química , Adenosina Difosfato Ribosa/farmacología , Adenosina Difosfato Ribosa/fisiología , ADP-Ribosa Cíclica , Imitación Molecular
14.
J Am Chem Soc ; 123(36): 8750-9, 2001 Sep 12.
Artículo en Inglés | MEDLINE | ID: mdl-11535079

RESUMEN

The synthesis of cyclic ADP-carbocyclic-ribose (cADPcR, 4) designed as a stable mimic of cyclic ADP-ribose (cADPR, 1), a Ca2+-mobilizing second messenger, was achieved using as the key step a condensation reaction with the phenylthiophosphate-type substrate 14 to form an intramolecular pyrophosphate linkage. The N-1-carbocyclic-ribosyladenosine derivative 16 was prepared via the condensation between the imidazole nucleoside derivative 17, prepared from AICA-riboside (19), and the readily available optically active carbocyclic amine 18. Compound 16 was then converted to the corresponding 5' '-phosphoryl-5'-phenylthiophosphate derivatives 14. Treatment of 14 with AgNO3 in the presence of molecular sieves (3 A) in pyridine at room temperature gave the desired cyclization product 32 in 93% yield, and subsequent acidic treatment provided the target cADPcR (4). This represents a general method for synthesizing biologically important cyclic nucleotides of this type. 1H NMR analysis of cADPcR suggested that its conformation in aqueous medium is similar to that of cADPR. cADPcR, unlike cADPR, was stable under neutral and acidic conditions, where under basic conditions, it formed the Dimroth-rearranged N6-cyclized product 34. cADPcR was also stable in rat brain membrane homogenate which has cADPR degradation activity. Furthermore, cADPcR was resistant to the hydrolysis by CD38 cADPR hydrolase, while cADPR was rapidly hydrolyzed under the same conditions. When cADPcR was injected into sea urchin eggs, it caused a significant release of Ca2+ in the cells, an effect considerably stronger than that of cADPR. Thus, cADPcR was identified as a stable mimic of cADPR.


Asunto(s)
Adenosina Difosfato Ribosa/análogos & derivados , Adenosina Difosfato Ribosa/química , Adenosina Difosfato Ribosa/síntesis química , Adenosina Difosfato Ribosa/metabolismo , Antígenos CD , Antígenos de Diferenciación/metabolismo , Calcio/metabolismo , Imitación Molecular , NAD+ Nucleosidasa/metabolismo , Sistemas de Mensajero Secundario/fisiología , ADP-Ribosil Ciclasa , ADP-Ribosil Ciclasa 1 , Animales , Encéfalo/metabolismo , ADP-Ribosa Cíclica , Estabilidad de Medicamentos , Escherichia coli/enzimología , Glicoproteínas de Membrana , Óvulo/metabolismo , Ratas , Erizos de Mar
15.
Artículo en Inglés | MEDLINE | ID: mdl-10772708

RESUMEN

The synthesis of cyclic ADP-carbocyclic-ribose (2), as a stable mimic for cyclic ADP-ribose, was investigated. Construction of the 18-membered backbone structure was successfully achieved by condensation of the two phosphate groups of 19, possibly due to restriction of the conformation of the substrate in a syn-form using an 8-chloro substituent at the adenine moiety. SN2 reactions between an optically active carbocyclic unit 8, which was constructed by a previously developed method, and 8-bromo-N6-trichloroacetyl-2',3'-O-isopropylideneadenosine 9c gave N-1-carbocyclic derivative, which was deprotected to give 5'-5"-diol derivatives 18. When 18 was treated with POCl3 in PO(OEt)3, the bromo group at the 8-position was replaced to give N-1-carbocyclic-8-chloroadenosine 5',5"-diphosphate derivative 19 in 43% yield. Treatment of 19 with 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride gave the desired intramolecular condensation product 20 in 10% yield. This is the first chemical construction of the 18-membered backbone structure containing an intramolecular pyrophosphate linkage of a cADPR-related compound with an adenine base.


Asunto(s)
Adenina/química , Adenosina Difosfato Ribosa/análogos & derivados , Halógenos/química , Adenosina Difosfato Ribosa/síntesis química , Adenosina Difosfato Ribosa/química , ADP-Ribosa Cíclica , Difosfatos/química , Espectroscopía de Resonancia Magnética
16.
Biochim Biophys Acta ; 1413(3): 139-46, 1999 Nov 10.
Artículo en Inglés | MEDLINE | ID: mdl-10556626

RESUMEN

Arylazido-beta-alanine ADP-ribose, a photoreactive analogue of ADP-ribose, was synthesized. In the dark, arylazido-beta-alanine ADP-ribose acts as a competitive reversible inhibitor of mitochondrial NADH-ubiquinone reductase with a K(i) of 37 microM. Upon photolysis, arylazido-beta-alanine ADP-ribose is converted to a potent irreversible active site-directed inhibitor of the enzyme. Photo-induced inhibition of membrane-bound NADH-ubiquinone reductase by arylazido-beta-alanine ADP-ribose is incomplete and results in a 20-fold reduction of the NADH oxidase and 2.5-fold reduction of the energy-dependent NAD(+) reductase activities. The arylazido-beta-alanine ADP-ribose resistant activities (direct and reverse) of the enzyme are characterized by a two orders of magnitude lower affinity to the corresponding substrates compared to those of the uninhibited NADH-ubiquinone reductase. A different kinetic behavior of the inhibited and native enzyme can be explained by invoking the two catalytically competent nucleotide-binding sites model of NADH-ubiquinone reductase.


Asunto(s)
Adenosina Difosfato Ribosa/análogos & derivados , Inhibidores Enzimáticos/farmacología , Mitocondrias Cardíacas/enzimología , NADH NADPH Oxidorreductasas/antagonistas & inhibidores , Adenosina Difosfato Ribosa/síntesis química , Adenosina Difosfato Ribosa/farmacología , Animales , Azidas/química , Sitios de Unión , Bovinos , Complejo I de Transporte de Electrón , Cinética , NAD/análogos & derivados , NAD/química , NAD+ Nucleosidasa/química , Fotólisis
17.
Biochim Biophys Acta ; 1472(3): 555-64, 1999 Nov 16.
Artículo en Inglés | MEDLINE | ID: mdl-10564770

RESUMEN

Cyclic 3-deaza-adenosine diphosphoribose (3-deaza-cADPR), an analog of cyclic adenosine diphosphoribose (cADPR) was synthesized. 3-deaza-cADPR differs from cADPR by only the substitution of carbon for nitrogen at the 3-position of the purine ring. Similar to cADPR, the analog has potent calcium releasing activity in sea urchin egg homogenates and was able to induce calcium release at concentrations as low as 0.3 nM. The EC(50) value for 3-deaza-cADPR-induced calcium release was 1 nM, which is about 70 times more potent than cADPR. The properties of calcium release induced by 3-deaza-cADPR in all other respects were similar to those of cADPR. Thus, 3-deaza-cADPR and cADPR were capable of cross-desensitizing each other and their calcium releasing activities were potentiated by Sr(2+) as well as caffeine. 8-amino-cADPR, a selective antagonist of cADPR, was also able to inhibit 3-deaza-cADPR induced calcium release. Taken together, these data suggest that 3-deaza-cADPR releases calcium through the same mechanism as cADPR. 3-deaza-cADPR was found to be resistant to both heat and enzymatic hydrolysis. Only 15% of 3-deaza-cADPR was destroyed after boiling this compound for 2 h. No loss of 3-deaza-cADPR was observed when treated with CD38 under conditions where cADPR was completely hydrolyzed. Thus, 3-deaza-cADPR is a potent and stable analog of cADPR. These properties should make 3-deaza-cADPR a useful probe in studies focused on the mechanism of cADPR action.


Asunto(s)
Adenosina Difosfato Ribosa/análogos & derivados , Adenosina Difosfato Ribosa/síntesis química , Adenosina Difosfato Ribosa/farmacología , Compuestos de Anilina , Animales , Calcio/metabolismo , ADP-Ribosa Cíclica , Embrión no Mamífero , Calor , Microinyecciones , Estructura Molecular , Erizos de Mar , Xantenos
18.
Bioorg Med Chem ; 7(5): 653-64, 1999 May.
Artículo en Inglés | MEDLINE | ID: mdl-10400320

RESUMEN

The objective of this brief review is to present an overview of the bioorganic chemistry of cyclic-ADP-ribose (cADPR) with special emphasis on the methodology used for the synthesis of analogues of cADPR. New structural analogues of cADPR can be prepared using either the biomimetic method or ADP-ribosyl cyclase from Aplysia californica. For the most part, both procedures give similar product profiles, but higher yields are generally obtained with the enzymatic method. These synthetic methodologies have allowed the transformation of a variety of structurally modified analogues of NAD+ into their corresponding cyclic nucleotides. Several of these novel analogues are more potent than cADPR in inducing calcium release and are also more stable towards degradative enzymes. They could serve as valuable affinity probes for the isolation of cADPR-binding proteins.


Asunto(s)
Adenosina Difosfato Ribosa/análogos & derivados , Antígenos CD , ADP-Ribosil Ciclasa , ADP-Ribosil Ciclasa 1 , Adenosina Difosfato Ribosa/biosíntesis , Adenosina Difosfato Ribosa/síntesis química , Adenosina Difosfato Ribosa/química , Adenosina Trifosfato/química , Marcadores de Afinidad/síntesis química , Animales , Antígenos de Diferenciación/química , ADP-Ribosa Cíclica , Estabilidad de Enzimas , Hidrólisis , Isomerismo , Modelos Químicos , NAD+ Nucleosidasa/química , Conformación Proteica , Erizos de Mar/embriología
19.
Nucleic Acids Symp Ser ; (42): 11-2, 1999.
Artículo en Inglés | MEDLINE | ID: mdl-10780354

RESUMEN

An efficient synthesis of cyclic IDP-carbocyclic-ribose, as a stable mimic for cyclic ADP-ribose, was achieved. 8-Bromo-N1-carbocyclic-ribosylinosine derivative 10, prepared from N1-(2,4-dinitrophenyl)inosine derivative 5 and an optically active carbocyclic amine 6, was converted to 8-bromo-N1-carbocyclic-ribosylinosine bisphosphate derivative 15. Treatment of 15 with I2 in the presence of molecular sieves in pyridine gave the desired cyclic product 16 quantitatively, which was deprotected and reductively debrominated to give the target cyclic IDP-carbocyclic-ribose (3).


Asunto(s)
Adenosina Difosfato Ribosa/análogos & derivados , Inosina Difosfato/análogos & derivados , Nucleótidos de Inosina/síntesis química , Adenosina Difosfato Ribosa/síntesis química , Adenosina Difosfato Ribosa/química , ADP-Ribosa Cíclica , Diseño de Fármacos , Indicadores y Reactivos , Inosina Difosfato/síntesis química , Inosina Difosfato/química , Nucleótidos de Inosina/química , Estructura Molecular , Sistemas de Mensajero Secundario
20.
Chem Biol ; 4(1): 51-61, 1997 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-9070427

RESUMEN

BACKGROUND: Cyclic adenosine 5'-diphosphate ribose (cADPR), a naturally occurring metabolite of nicotinamide adenine dinucleotide (NAD+), mobilizes Ca2+ from non-mitochondrial stores in a variety of mammalian and invertebrate tissues. It has been shown that cADPR activates ryanodine-sensitive Ca(2+)-release channels, working independently of inositol 1,4,5-trisphosphate (IP3) to mobilize intracellular Ca2+ stores. In some systems, cADPR has been shown to be more potent than IP3. The chemo-enzymatic synthesis of structurally modified analogues of cADPR can provide pharmacological tools for probing this new Ca(2+)-signaling pathway. In this work, we describe the synthesis and evaluation of a structural mimic of cADPR with different Ca(2+)-releasing properties. RESULTS: 7-Deaza cyclic adenosine 5'-diphosphate ribose (7-deaza cADPR), a novel cADPR analogue modified in the purine ring, was synthesized and its ability to release Ca2+ from non-mitochondrial pools in homogenates made from sea urchin eggs was investigated. 7-Deaza cADPR was more effective in releasing Ca2+ than cADPR, but it only released approximately 66% of the Ca2+ released by a maximal concentration of cADPR. It was also more resistant to hydrolysis than cADPR. If we administered increasing concentrations of 7-deaza cADPR at the same time as a maximal concentration of cADPR, the induction of Ca2+ release by cADPR was antagonized. CONCLUSIONS: 7-Deaza cADPR has a Ca(2+)-release profile consistent with that of a partial agonist, and it is the first reported example of such a compound to act at the cADPR receptor. The imidazole ring of cADPR is clearly important in stimulating the Ca(2+)-release machinery, and the present results demonstrate that structural modification of a site other than position 8 of the purine ring can affect the efficacy of Ca2+ release. 7-Deaza cADPR represents a significant step forwards in designing modulators of the cADPR signaling pathway.


Asunto(s)
Adenosina Difosfato Ribosa/análogos & derivados , Calcio/metabolismo , Oocitos/metabolismo , Adenosina Difosfato Ribosa/síntesis química , Adenosina Difosfato Ribosa/metabolismo , Adenosina Difosfato Ribosa/farmacología , Animales , ADP-Ribosa Cíclica , Proteínas de Unión al GTP/metabolismo , Indicadores y Reactivos , Inositol 1,4,5-Trifosfato/metabolismo , Cinética , Espectroscopía de Resonancia Magnética , Modelos Biológicos , Estructura Molecular , Oocitos/efectos de los fármacos , Fosfatidilinositol 4,5-Difosfato/metabolismo , Erizos de Mar , Sistemas de Mensajero Secundario , Relación Estructura-Actividad , Tritio
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA